Walmart is already rolling back its bold clinic strategy.Walmart Health
Hello,
Advertisement
Hope you all had a lovely short week! I spent my day yesterday out skiing. While it was strange to take a random weekday off, it was lovely to avoid the crowds on the weekends.
It's been about two years since we first started hearing about Walmart's latest healthcare ambitions. The idea was to build out health centers that could do everything from primary care to dentist appointments for the communities Walmart was in.
Despite the high expectations, Shelby Livingston and Blake Dodge have learned that Walmart is pulling back on its health center plans. Changes in leadership and the pandemic have influenced a more conservative plan from the initial goal of having 4,000 clinics by 2029, they learned through conversations with former and current employees as well as leaked documents.
After CVS's fourth-quarter earnings, Shelby chatted with the company's new CEO about what's ahead for the business.
Karen Lynch became CEO on February 1 after serving as the president of CVS's Aetna business.
It's been three years since CVS bought Aetna, and part of Lynch's job will be connecting the different parts of the business as it pushes deeper into the healthcare business through medical care and insurance.
You might recall a few week's back I asked y'all if you had any thoughts on the way Big Tech funds its healthcare ventures, and whether it's working for them.
Well, Blake and Hugh Langley have come to a conclusion in their most recent reporting.
Talking to employees at the health bets, industry insiders, and executives, they found that there's a lot that can get in the way of a tech company's healthcare ambitions.
Next week will be a key week in the COVID-19 vaccine race, as the Food and Drug Administration published an analyst of Johnson & Johnson's data and an expert panel publicly reviews it.
It's easy to hear coronavirus these days and just think of COVID-19 and the unfolding pandemic.
But coronaviruses are responsible for more than just COVID-19 - they're also the virus that can cause the common cold, SARS, and more.
Allison DeAngelis spent some time this week digging into the biotechs looking at making universal coronavirus drugs. The hope is to protect people from COVID-19 as well as future conditions caused by coronaviruses.
NewsletterSIMPLY PUT - where we join the dots to inform and inspire you. Sign up for a weekly brief collating many news items into one untangled thought delivered straight to your mailbox.
Next Story
I quit McKinsey after 1.5 years. I was making over $200k but my mental health was shattered.
Some Tesla factory workers realized they were laid off when security scanned their badges and sent them back on shuttles, sources say
I tutor the children of some of Dubai's richest people. One of them paid me $3,000 to do his homework.
Why are so many elite coaches moving to Western countries?
Global GDP to face a 19% decline by 2050 due to climate change, study projects
5 things to keep in mind before taking a personal loan
Markets face heavy fluctuations; settle lower taking downtrend to 4th day
Move over Bollywood, audio shows are starting to enter the coveted ‘100 Crores Club’
